mefloquine + artesunate Tablets 250 mg + 100 mg, 250 mg + 200 mg,

This pharmaceutical company is dedicated to improving global health through the production of high-quality, affordable medications. Established in 2009, they hold a manufacturing license and operate within a prominent industrial zone. Their product portfolio encompasses injections (both psychotropic and general) as well as tablets and capsules. They specialize in treating various conditions including viral infections, mental health disorders, cardiovascular issues, and digestive problems. Dosage forms include both parenteral (injections) and oral options. The company prioritizes adherence to international standards and aims to make essential medicines accessible worldwide.